• Alleviated cognitive impairment in AD rats• Reduced Aβ deposition• Reduced TNF-α and IL-1β levels• Decreased expression of TLR4, MyD88, TRIF, and downstream effectors including NF-κB and IRF3. This evidence concerns the gene TNF and Cognitive impairment.